Control Bionics Ltd. (AU:CBL) has released an update.
Control Bionics Ltd., a medical device company specializing in communication-assisting technology, has announced a strategic investment of $0.525 million through North Star Impact Fund. The fund has purchased 10 million new shares at a slight discount, with the capital raised to be directed towards general working capital purposes. CEO Jeremy Steele expresses enthusiasm about the partnership with North Star, anticipating accelerated growth for Control Bionics.
For further insights into AU:CBL stock, check out TipRanks’ Stock Analysis page.
